Phénix
Phénix is a nuclear reactor that was operational in France from 1973 to 2009. It was a fast breeder reactor, a type of reactor designed to produce more fissile material than it consumes, thus "breeding" fuel. Phénix was part of the French government's long-term strategy for energy independence, which included the development of a closed nuclear fuel cycle where spent fuel would be reprocessed and reused.
History
Phénix was constructed in the early 1970s as part of a French government initiative to develop a nuclear power industry that could provide the country with a reliable and independent source of energy. The reactor was designed and built by the French Atomic Energy Commission (CEA), and it began operation in 1973.
Over its 36 years of operation, Phénix produced a significant amount of electricity for the French grid and contributed to the development of the country's nuclear industry. The reactor was also used for research purposes, particularly in the field of nuclear transmutation, a process that can reduce the volume and toxicity of nuclear waste.
Phénix was shut down in 2009, and it is currently in the process of being decommissioned. The lessons learned from its operation have been used in the design of the Astrid project, a new generation of fast breeder reactors.
Design and operation
Phénix was a sodium-cooled fast reactor, a type of fast breeder reactor that uses liquid sodium as a coolant. This design allows the reactor to operate at high temperatures and makes it possible to use a wide range of fuels, including plutonium and minor actinides.
The reactor had a thermal power of 590 MW and an electrical power of 233 MW. It used a mixed oxide (MOX) fuel, which is a blend of plutonium and natural or depleted uranium. The fuel was arranged in a core surrounded by a blanket of fertile material, which could be converted into fissile material by the neutrons produced in the core.
Legacy
The operation of Phénix provided valuable experience and data for the French nuclear industry. It demonstrated the feasibility of fast breeder reactors and contributed to the development of the closed nuclear fuel cycle in France. The lessons learned from Phénix have been used in the design of the Astrid project, which aims to develop a new generation of fast breeder reactors. Template:France-energy-stub
This nuclear technology related article is a stub. You can help WikiMD by expanding it.
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian